DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,881,711 | +14.3% | 88,197 | +10.6% | 0.72% | +8.2% |
| Q2 2023 | $19,146,514 | -0.4% | 79,777 | +4.6% | 0.67% | -2.8% |
| Q1 2023 | $19,218,086 | -3.5% | 76,250 | +1.6% | 0.69% | -9.2% |
| Q4 2022 | $19,919,012 | +4.2% | 75,047 | +1.4% | 0.76% | -3.9% |
| Q3 2022 | $19,110,000 | +4.5% | 73,988 | +2.6% | 0.79% | +9.7% |
| Q2 2022 | $18,288,000 | -14.6% | 72,136 | -1.2% | 0.72% | 0.0% |
| Q1 2022 | $21,410,000 | -8.9% | 72,991 | +2.2% | 0.72% | -3.9% |
| Q4 2021 | $23,493,000 | +8.1% | 71,406 | +0.1% | 0.75% | +0.8% |
| Q3 2021 | $21,728,000 | +34.6% | 71,370 | +18.7% | 0.74% | +33.2% |
| Q2 2021 | $16,139,000 | +21.0% | 60,141 | +1.5% | 0.56% | +13.0% |
| Q1 2021 | $13,337,000 | -0.3% | 59,255 | -1.6% | 0.49% | -19.0% |
| Q4 2020 | $13,376,000 | -1.8% | 60,215 | -4.8% | 0.61% | -13.5% |
| Q3 2020 | $13,619,000 | +22.3% | 63,247 | +0.5% | 0.70% | +13.3% |
| Q2 2020 | $11,133,000 | +36.1% | 62,958 | +6.6% | 0.62% | +6.9% |
| Q1 2020 | $8,178,000 | -2.0% | 59,082 | +8.6% | 0.58% | +23.8% |
| Q4 2019 | $8,348,000 | +33.7% | 54,390 | +25.8% | 0.47% | +24.3% |
| Q3 2019 | $6,246,000 | +1.1% | 43,246 | +0.0% | 0.38% | 0.0% |
| Q2 2019 | $6,180,000 | -25.2% | 43,244 | -30.9% | 0.38% | -26.2% |
| Q1 2019 | $8,260,000 | +21.6% | 62,565 | -5.0% | 0.51% | +11.5% |
| Q4 2018 | $6,795,000 | -3.7% | 65,891 | +1.4% | 0.46% | +11.1% |
| Q3 2018 | $7,059,000 | +3.7% | 64,965 | -5.8% | 0.41% | +1.7% |
| Q2 2018 | $6,809,000 | -4.4% | 68,997 | -5.1% | 0.41% | -10.6% |
| Q1 2018 | $7,120,000 | -5.1% | 72,716 | -10.1% | 0.45% | -3.8% |
| Q4 2017 | $7,504,000 | +53.4% | 80,842 | +41.7% | 0.47% | +24.5% |
| Q3 2017 | $4,893,000 | +10.0% | 57,047 | +8.2% | 0.38% | +5.0% |
| Q2 2017 | $4,449,000 | -1.2% | 52,722 | +0.1% | 0.36% | -3.5% |
| Q1 2017 | $4,504,000 | +69.0% | 52,665 | +53.8% | 0.37% | +51.4% |
| Q4 2016 | $2,665,000 | +27.3% | 34,234 | +28.2% | 0.25% | +28.0% |
| Q3 2016 | $2,093,000 | -3.9% | 26,696 | +23.7% | 0.19% | -25.8% |
| Q2 2016 | $2,179,000 | +247.5% | 21,573 | +226.4% | 0.26% | +195.5% |
| Q1 2016 | $627,000 | +68.5% | 6,610 | +51.4% | 0.09% | +51.7% |
| Q3 2015 | $372,000 | -19.0% | 4,365 | -18.6% | 0.06% | -18.3% |
| Q2 2015 | $459,000 | -52.9% | 5,365 | -57.5% | 0.07% | -54.8% |
| Q4 2013 | $975,000 | -1.8% | 12,630 | -11.9% | 0.16% | -16.9% |
| Q3 2013 | $993,000 | +3.9% | 14,330 | -5.1% | 0.19% | +8.6% |
| Q2 2013 | $956,000 | – | 15,100 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |